Title: Teratogen update: Azathioprine and 6‐mercaptopurine
Abstract: TeratologyVolume 65, Issue 5 p. 240-261 ArticleFull Access Teratogen update: Azathioprine and 6-mercaptopurine Janine E. Polifka, Corresponding Author Janine E. Polifka [email protected] TERIS Project, University of Washington, Seattle, Washington 98195-7920TERIS Box 357920, University of Washington, Seattle, WA 98195-7920Search for more papers by this authorJ.M. Friedman, J.M. Friedman Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V6T 1Z3Search for more papers by this author Janine E. Polifka, Corresponding Author Janine E. Polifka [email protected] TERIS Project, University of Washington, Seattle, Washington 98195-7920TERIS Box 357920, University of Washington, Seattle, WA 98195-7920Search for more papers by this authorJ.M. Friedman, J.M. Friedman Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V6T 1Z3Search for more papers by this author First published: 11 April 2002 https://doi.org/10.1002/tera.10043Citations: 164AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat LITERATURE CITED Ahlswede KM, Ahlswede BA, Jarrell BE, Moritz MJ, Armenti, VT. 1994. National Transplantation Pregnancy Registry: Outcomes of pregnancies fathered by male transplant recipients. In: DR Mattison, AF Olshan, editors. Male-mediated developmental toxicity. New York: Plenum Press. p 335–338. Alexandrov VA. 1973. Embryotoxic and teratogenic effects of chemical carcinogens. IARC Sci Publ 4: 112–126. Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJG, Clark ML. 1990. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 99: 443–446. Amemiya K, Hurley LS, Keen CL. 1989. Effect of 6-mercaptopurine on 65Zn distribution in the pregnant rat. Teratology 39: 387–393. Amemiya K, Keen CL, Hurley LS. 1986. 6-Mercaptopurine-induced alterations in mineral metabolism and teratogenesis in the rat. Teratology 34: 321–334. Andersen JB, Szumlanski C, Weinshilboum RM, Schmiegelow K. 1998. Pharmacokinetics, dose adjustments, and 6-mercaptopurine/methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency. Acta Pediatr 87: 108–111. Armenti VT, Ahlswede KM, Ahlswede BA, Cater JR, Jarrell BE, Moritz MJ, Burke JF Jr. 1995. Variables affecting birthweight and graft survival in 197 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 59: 476–476. Armenti VT, Ahlswede KM, Ahlswede BA, Jarrell BE, Moritz MJ, Burke JF. 1994. National Transplantation Pregnancy Registry—outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 57: 502–506. Armenti VT, Ahlswede BA, Moritz MJ, Jarrell BE. 1993. National Transplantation Pregnancy Registry: analysis of pregnancy outcomes of female kidney recipients with relation to time interval from transplant to conception. Transplant Proc 25: 1036–1037. Arndt CAS, Balis FM, McCully CL, Jeffries SL, Doherty K, Murphy R, Poplack DG. 1988. Bioavailability of low-dose vs. high-dose 6-mercaptopurine. Clin Pharmacol Ther 43: 588–591. Atkison P, Joubert G, Barron A, Grant D, Paradis K, Seidman E, Wall W, Rosenberg H, Howard J, Williams S, et al. 1995. Hypertrophic cardiomyopathy associated with tacrolimus in pediatric transplant patients. Lancet 345: 894–896. Aviles A, Diaz-Maqueo JC, Talavera A, Guzman R, Garcia EL. 1991. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol 36: 243–248. Awidi AS, Tarawneh MS, Shubair KS, Issa AA, Dajani YF. 1983. Acute leukemia in pregnancy: report of five cases treated with a combination which included a low dose of adriamycin. Eur J Cancer Clin Oncol 19: 881–884. Baarsma R, Kamps WA. 1993. Immunological responses in an infant after cyclosporine A exposure during pregnancy. Eur J Pediatr 152: 476–477. Bacon C, Kernahan J. 1975. Successful pregnancy in acute leukemia. Lancet 2: 515. Barkhan P, Evans PR. 1976. Conception and congenital abnormalities after chemotherapy for leukanemia. Br Med J 2: 816–817. Baruch Y, Weiner Z, Enat R, Ronen N, Blumenfeld Z. 1993. Pregnancy after liver transplantation. Int J Gynecol Obstet 41: 273–276. Baruch Y, Weitzman E, Markiewicz W, Eisenman A, Eid A, Enat R. 1996. Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral. Transplant Proc 28: 2250–2251. Baxi LV, Rho RB. 1993. Pregnancy after cardiac transplantation. Am J Obstet Gynecol 169: 33–34. Ben Hamida F, Ben Abdallah T, Barbouch S, Laabidi J, Abderrahim E, Goucha R, Hedri H, el Younsi F, Ben Moussa F, Kheder MA, Ben Maïz H. 1999. Four successful pregnancies following kidney transplantation. Transplant Proc 31: 3146–3147. Ben-Neriah Z, Ackerman Z. 2001. WAGR syndrome in a baby—the result of 6-MP treatment in a father affected by Crohn disease? Am J Gastroenterol 96: 251. Bererhi L, Bedrossian J, Metivier F, Duboust A, Fornairon S, Marrast AC, Idatte JM. 1997. Pregnancy in kidney transplantation: past and present experience. Transplant Proc 29: 2478. Bermas BL, Hill JA. 1995. Effects of immunosuppressive drugs during pregnancy. Arthritis Rheum 38: 1722–1732. Bieber S, Dietrich LS, Elion BG, Hitchings GH, Martin DS. 1961. The incorporation of 6-mercaptopurine-S-35 into the nucleic acids of sensitive and non-sensitive transplantable mouse tumors. Cancer Res 21: 228–231. Bishop JB, Witt KL, Sloane RA. 1997. Genetic toxicities of human teratogens. Mutat Res 396: 9–43. Blanchard WB, Bucciarelli RL, Miller BL. 1979. Ventricular parasystole in a newborn infant. J Electrocardiol 12: 427–429. Blatt J, Mulvihill JJ, Ziegler JL, Young RC, Poplack DG. 1980. Pregnancy outcome following cancer chemotherapy. Am J Med 69: 828–832. Board JA, Lee HM, Draper DA, Hume DM. 1967. Pregnancy following kidney homotransplantation from a non-twin. Report of a case with concurrent administration of azathioprine and prednisone. Obstet Gynecol 29: 318–323. Bokkerink JP, Stet EH, De Abreu RA, Damen FJ, Hulscher TW, Bakker MA, van Baal JA. 1993. 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts. Biochem Pharmacol 45: 1455–1463. Bostrom B, Erdmann G. 1993. Cellular pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 15: 80–86. Botoman VA, Bonner GF, Botoman DA. 1998. Management of inflammatory bowel disease. Am Fam Physician 57: 57–72. Bragonier JR, Carver MJ. 1968. The influence of 6-mercaptopurine on rat placenta and fetus. Biochem Pharmacol 17: 1689–1697. Bragonier JR, Roesky N, Carver MJ. 1964. Teratogenesis: Effects of substituted purines and the influence of 4-hydroxypyrazolopyrimidine in the rat. Proc Soc Exp Biol Med 116: 685–688. Brent LH, Beckman DA, Brent RL. 1997. The effects of antirheumatic drugs on reproductive function. Reprod Toxicol 11: 561–577. Brent RL. 1986. Definition of a teratogen and the relationship of teratogenicity to carcinogenicity. Teratology 34: 359–360. Breter HJ. 1985. The quantitative determination of metabolites of 6-mercaptopurine in biological materials. VI. Evidence for posttranscriptional modification of 6-thioguanosine residues in RNA from L5178Y cells treated with 6-mercaptopurine. Biochim Biophys Acta 825: 39–44. Brown JH, Maxwell AP, McGeown MG. 1991. Outcome of pregnancy following renal transplantation. Ir J Med Sci 160: 255–256. Burdett DN, Waterfield JD, Shah RM. 1988. Vertical development of the secondary palate in hamster embryos following exposure to 6-mercaptopurine. Teratology 37: 591–597. Burleson RL, Sunderji SG, Aubry RH, Clark DA, Marbarger P, Cohen RS, Scruggs BF, LaGraff S. 1983. Renal allotransplantation during pregnancy. Successful outcome for mother, child, and kidney. Transplantation 36: 334–335. Byrne J. 1999. Long-term genetic and reproductive effects of ionizing radiation and chemotherapeutic agents on cancer patients and their offspring. Teratology 59: 210–215. Camann WR, Goldman GA, Johnson MD, Moore J, Greene M. 1989. Cesarean delivery in a patient with a transplanted heart. Anesthesiology 71: 618–620. Camann WR, Jarcho JA, Mintz KJ, Greene MF. 1991. Uncomplicated vaginal delivery 14 months after cardiac transplantation. Am Heart J 121: 939–941. Caplan RM, Dossetor JB, Maughan GB. 1970. Pregnancy following cadaver kidney homotransplantation. Am J Obstet Gynecol 106: 644–648. Cararach V, Carmona F, Monleón FJ, Andreu J. 1993. Pregnancy after renal transplantation: 25 years experience in Spain. Br J Obstet Gynecol 100: 122–125. Castiglione F, Del Vecchio Blanco G, Rispo A, Cozzolino A, Di Girolamo E, Cappuccio D, Mazzacca G. 2000. Hepatitis related to cytomegalovirus infection in two patients with Crohn disease treated with azathioprine. Dig Liver Dis 32: 626–629. Chabner BA, Allegra CJ, Curt GA, Calabresi P. 1996. Antineoplastic agents. In: JG Hardman, LE Limbird, PB Molinoff, RW Ruddon, AG Gilman, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 9th Ed. New York: McGraw-Hill. p 1233–1287. Chan GLC, Erdmann GR, Gruber SA, Matas AJ, Canafax DM. 1990. Azathioprine metabolism: Pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients. J Clin Pharmacol 30: 358–363. Chaub S, Murphy ML. 1968. The teratogenic effects of the recent drugs active in cancer chemotherapy. Adv Teratol 3: 181–237. Chinayon P, Sakornpant P. 1994. Successful pregnancy after heart-lung transplantation: a case report. Asia Oceania J Obstet Gynecol 20: 275–278. Chrzanowska M, Kolecki P, Duczmal-Cichocka B, Fiet J. 1999. Metabolites of mercaptopurine in red blood cells: a relationship between 6-thioguanine nucleotides and 6-methylmercaptopurine metabolite concentrations in children with lymphoblastic leukemia. Eur J Pharm Sci 8: 329–334. Clark JM. 1975. The mutagenicity of azathioprine in mice, Drosophila melanogaster and Neurospora crassa. Mutat Res 28: 87–99. Collie-Duguid ES, Pritchard SC, Powrie RH, Sludden J, Li T, McLeod HL. 1999. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 9: 37–42. Cooper K, Stafford J, Turner-Warwick M. 1970. Wegener granuloma complicating pregnancy. J Obstet Gyneacol Br Commonw 77: 1028–1030. Coopland AT, Friesen WJ, Galbraith PA. 1969. Acute leukemia in pregnancy. Am J Obstet Gynecol 105: 1288–1289. Coté CJ, Meuwissen HJ, Pickering RJ. 1974. Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy. J Pediatr 85: 324–328. Coulam CB, Zincke H, Sterioff S. 1982. Pregnancy after renal transplantation: estrogen secretion. Transplantation 33: 556–558. Cozzi R, Palitti F, Fiore M, Mosesso P, Ricordy R, Tanzarella C. 1983. Induction of chromosomal damage both in vitro and in vivo by 6-mercaptopurine. INSERM/EEMS 119: 229–232. Cuffari C, Hunt S, Bayless TM. 2000. Enhanced bioavailability of azathioprine compared to 6-mercaptopurine therapy in inflammatory bowel disease: correlation with treatment efficacy. Aliment Pharmacol Ther 14: 1009–1014. Dara P, Slater LM, Armentrout SA. 1981. Successful pregnancy during chemotherapy for acute leukemia. Cancer 47: 845–846. Davison JM. 1995. Toward long-term graft survival in renal transplantation: pregnancy. Nephrol Dial Transplant 10(Suppl): 85–89. Davison JM, Dellagrammatikas H, Parkin JM. 1985. Maternal azathioprine therapy and depressed hemopoiesis in the babies of renal allograft patients. Br J Obstet Gynecol 92: 233–239. DeWitte DB, Buick MK, Cyran SE, Maisels MJ. 1984. Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone. J Pediatr 105: 625-628. Diamond I, Anderson MM, McCreadie SR. 1960. Transplacental transmission of busulfan (Myleran®) in a mother with leukemia. Pediatrics 25: 85–90. Diasio RB, LoBuglio AF. 1996. Immunomodulators: Immunosuppressive agents and immunostimulants. In: JG Hardman, LE Limbird, PB Molinoff, RW Ruddon, AG Gilman, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 9th Ed. New York: McGraw-Hill. p 1291–1308. Ding TL, Benet LZ. 1979. Comparative bioavailability and pharmacokinetic studies of azathioprine and 6-mercaptopurine in the rhesus monkey. Drug Metab Dispos 7: 373–377. Doney KC, Kraemer KG, Shepard TH. 1979. Combination chemotherapy for acute myelocytic leukemia during pregnancy: three case reports. Cancer Treat Rep 63: 369–371. Dreosti IE, Hurley LS. 1975. Depressed thymidine kinase activity in zinc-deficient rat embryos. Proc Soc Exp Biol Med 150: 161–165. Duncan JR, Hurley LS. 1977. DNA synthetic enzyme activities in zinc-deficient embryos. Fed Proc 36: 1176. Eckhert CD, Hurley LS. 1977. Reduced DNA synthesis in zinc deficiency: regional differences in embryonic rats. J Nutr 107: 855–861. Elion GB. 1967. Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues. Fed Proc 26: 898–903. Erkman J, Blythe JG. 1972. Azathioprine therapy complicated by pregnancy. Obstet Gynecol 40: 708–710. Ersay A, Oygür N, Coskun M, Süleymanlar G, Trak B, Yeğin O. 1995. Immunologic evaluation of a neonate born to an immunosuppressed kidney transplant recipient. Am J Perinatol 12: 413–415. Esplin MS, Branch DW. 1997. Immunosuppressive drugs and pregnancy. Obstet Gynecol Clin North Am 24: 601–616. Evenson DP, Arlin Z, Welt S, Claps ML, Melamed MR. 1984. Male reproductive capacity may recover following drug treatment with the L-10 protocol for acute lymphocytic leukemia. Cancer 53: 30–36. Ewe K, Press AG, Singe CC, Stufler M, Ueberschaer B, Hommel G, Buschenfelde KHMZ. 1993. Azathioprine combined with prednisolone or monotherapy with prednisone in active Crohn disease. Gastroenterology 105: 367–372. Farber M, Kennison RD, Jackson HT, Sbarra AJ, Widmere B, Barnes BA. 1976. Successful pregnancy after renal transplantation. Obstet Gynecol 48(Suppl): 2S–4S. Fein A, Gross A, Serr DM, Nebel L. 1983. Effect of Imuran® on placental and fetal development in rats. Isr J Med Sci 19: 73–75. Feliu J, Juarez S, Ordoñez A, Garcia-Paredes ML, Gonzalez-Baron M, Montero JM. 1988. Acute leukemia and pregnancy. Cancer 61: 580–584. Framarino di Malatesta ML, Poli L, Pierucci F, Paolucci A, Pretagostini R, Di Nicuolo A, Berloco P, Alfani D, Piccioni MG, Veneziano M, Cortesini L, Marzetti L. 1993. Pregnancy and kidney transplantation: clinical problems and experience. Transplant Proc 25: 2188–2189. Francella A, Dayan A, Rubin P, Chapman M, Present D. 1996. 6-Mercaptopurine (6-MP) is safe therapy for child bearing patients with inflammatory bowel disease (IBD): a case controlled study. Gastroenterology 110: A909. Frenkel EP, Meyers MC. 1960. Acute leukemia and pregnancy. Ann Intern Med 53: 656–671. Gaffney K, Scott DGI. 1998. Azathioprine and cyclophosphamide in the treatment of rheumatoid arthritis. Br J Rheumatol 37: 824–836. Gasser C. 1980. Long-term survival (cures) in childhood acute leukemia. Follow-up of nine cases of acute lymphatic leukemia and two of acute myelogenous leukemia with complete remission lasting more than 10 years, three of them with normal progeny. Pediatrician 9: 344–357. Gebhardt DOE. 1983. Azathioprine teratogenicity: review of the literature and case report. Obstet Gynecol 61: 270. Generoso WM, Huff SW, Cain KT. 1975a. Comparative inducibility by 6-mercaptopurine of dominant-lethal mutations and heritable translocations in early meiotic male germ cells and differentiating spermatogonia of mice. Mutat Res 31: 341–342. Generoso WM, Preston RJ, Brewen JG. 1975b. 6-Mercaptopurine, an inducer of cytogenetic and dominant lethal effects in premeiotic and early meiotic germ cells of male mice. Mutat Res 28: 437–447. Georgiou PE, Politi EN, Katsimbri P, Sakka V, Drosos AA. 2000. Outcome of lupus pregnancy: a controlled study. Rheumatology 39: 1014–1019. Gevers RH, Hintzen AHJ, Kalff MW, Ruys JH, Dooren LJ. 1971. Schwangerschaff nach Nurentransplantation. Arch Gynakol 211: 330–331. Ghahramani N, Attaipour Y, Ghods AJ. 1993. Chromosomal aberrations among offspring of female renal transplant recipients. Transplant Proc 25: 2190. Gillibrand PN. 1966. Systemic lupus erythematosus in pregnancy treated with azathioprine. Proc R Soc Med 59: 834. Githens JH, Rosenkrantz JG, Tunnock SM. 1965. Teratogenic effects of azathioprine (Imuran). J Pediatr 66: 959–961. Golby M. 1970. Fertility after renal transplantation. Transplantation 10: 201–207. Goldstein F. 1987. Immunosuppressant therapy of inflammatory bowel disease. Pharmacologic and clinical aspects. J Clin Gastroenterol 9: 654–658. Green DM, Fiorello A, Zevon MA, Hall, B, Seigelstein N. 1997. Birth defects and childhood cancer in offspring of survivors of childhood cancer. Arch Pediatr Adolesc Med 151: 379–383. Grekas DM, Vasiliou SS, Lazarides AN. 1984. Immunosuppressive therapy and breast-feeding after renal transplantation. Nephron 37: 68. Ha J, Kim SJ, Kim ST. 1994. Pregnancy following renal transplantation. Transplant Proc 26: 2117–2118. Hadi HA, Stafford CR, Williamson JR, Fadel HE, Devoe LD. 1986. Pregnancy outcome in renal transplant recipients: experience at the Medical College of Georgia and review of the literature. South Med J 79: 959–964. Hanauer SB, Greenberger NJ. 1999. Updating the approach to Crohn disease. Hosp Pract 34: 77–94. Haugen G, Fauchald P, Sødal G, Leivestad T, Moe N. 1994. Pregnancy outcome in renal allograft recipients in Norway. The importance of immunosuppressive drug regimen and health status before pregnancy. Acta Obstet Gynecol Scand 73: 541–546. Henahan J. 1983. Pregnancy in kidney transplant recipients seems successful, but…. JAMA 249: 2287–2288. Heneghan MA, Norris SM, O'Grady JG, Harrison PM, McFarlane IG. 2001. Management and outcome of pregnancy in autoimmune hepatitis. Gut 48: 97–102. Hinkes E, Plotkin D. 1973. Reversible drug-induced sterility in a patient with acute leukemia. JAMA 223: 1490–1491. Hirsch KS, Hurley LS. 1978. Relationship of dietary zinc to 6-mercaptopurine teratogenesis and DNA metabolism in the rat. Teratology 17: 303–314. Holden HE, Ray VA, Wahrenburg MG, Zelenski JD. 1973. Mutagenicity studies with 6- mercaptopurine: I. Cytogenetic activity in vivo. Mutat Res 20: 257–263. Hoover BA, Schumacher HR. 1966. Acute leukemia in pregnancy. Am J Obstet Gynecol 96: 316–320. Hume DM, Lee HM, Williams GM, White HJO, Ferré J, Wolf JS, Prout GR Jr, Slapak M, O'Brien J, Kilpatrick SJ, Kauffman HM Jr, Cleveland RJ. 1966. Comparative results of cadaver and related donor renal homografts in man, and immunologic implications of the outcome of second and paired transplants. Ann Surg 164: 352–397. Huynh LA, Min DI. 1994. Outcomes of pregnancy and the management of immunosuppressive agents to minimize fetal risks in organ transplant patients. Ann Pharmacother 28: 1355–1357. Jacob ET, Grunstein S, Shapira Z, Berant M, Better OS, Boner G. 1974. Successful pregnancy in a recipient of a cadaver kidney allograft. Case report and review of the literature. Isr J Med Sci 10: 206–212. Janka-Schaub GE, Erb N, Harms D. 1994. Randomized comparison of 6-mercaptopurine vs. 6-thioguanine in maintenance treatment of childhood acute lymphoblastic leukemia (ALL): differing metabolism and hematologic toxicity. Med Ped Oncol 23: 197. Källén B. 1998. Drug treatment of rheumatic diseases during pregnancy. The teratogenicity of antirheumatic drugs—what is the evidence? Scand J Rheumatol Suppl 107: 119–124. Kaufman JJ, Dignam W, Goodwin WE, Martin DC, Goldman R, Maxwell MH. 1967. Successful normal childbirth after kidney homotransplantation. JAMA 200: 162–165. Key TC, Resnik R, Dittrich HC, Reisner LS. 1989. Successful pregnancy after cardiac transplantation. Am J Obstet Gynecol 160: 367–371. Khan ZH, Mayberry JF, Spiers N, Wicks AC. 2000. Retrospective case series analysis of patients with inflammatory bowel disease on azathioprine. A District General Hospital experience. Digestion 62: 249–254. Khurshid M, Saleem M. 1978. Acute leukemia in pregnancy. Lancet i: 534–535. Kirk EP. 1991. Organ transplantation and pregnancy. A case report and review. Am J Obstet Gynecol 164: 1629–1634. Kroner TH, Tschumi A. 1977. Conception of normal child during chemotherapy of acute lymphoblastic leukemia in the father. Br Med J 1: 1322–1323. Krueger JA, Davis RB, Field C. 1976. Multiple-drug chemotherapy in the management of acute lymphocytic leukemia during pregnancy. Obstet Gynecol 48: 324–327. Kurowski V, Iven H. 1991. Plasma concentrations and organ distribution of thiopurines after oral application of azathioprine in mice. Cancer Chemother Pharmacol 28: 7–14. Kury G, Chaube S, Murphy ML. 1968. Teratogenic effects of some purine analogues on fetal rat. Arch Pathol 86: 395–402. Laifer SA, Darby MJ, Scantlebury VP, Harger JH, Caritis SN. 1990. Pregnancy and liver transplantation. Obstet Gynecol 76: 1083–1088. Laifer SA, Guido RS. 1995. Reproductive function and outcome of pregnancy after liver transplantation in women. Mayo Clin Proc 70: 388–394. Leb DE, Weisskopf B, Kanovitz BS. 1971. Chromosome aberrations in the child of a kidney transplant recipient. Arch Intern Med 128: 441–444. Lee RA, Johnson CE, Hanlon DG. 1962. Leukemia during pregnancy. Am J Obstet Gynecol 84: 455–458. Lennard L. 1992. The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol 43: 329–339. Lennard L, Brown CB, Fox M, Maddocks JL. 1984. Azathioprine metabolism in kidney transplant recipients. Br J Clin Pharmacol 18: 693–700. Lepage GA, Whitecar JP. 1971. Pharmacology of 6-thioguanine in man. Cancer Res 31: 1627–1631. Levy N, Roisman I, Teodor I. 1981. Ulcerative colitis in pregnancy in Israel. Dis Colon Rectum 24: 351–354. Levy M, Buskila D, Gladman DD, Urowtiz MB, Koren G. 1991. Pregnancy outcome following first trimester exposure to chloroquine. Am J Perinatol 8: 174–178. Li FP, Jaffe N. 1974. Progeny of childhood-cancer survivors. Lancet 2: 707–709. Lower GD, Stevens LE, Najarian JS, Reemtsma K. 1971. Problems from immunosuppressives during pregnancy. Am J Obstet Gynecol 111: 1120–1121. Loyd HO. 1961. Acute leukemia complicated by pregnancy. JAMA 178: 1140–1143. MacDonald RS. 2000. The role of zinc of growth and cell proliferation. J Nutr 130: 1500S–1508S. Maier P, Schmid W. 1976. Ten model mutagens evaluated by the micronucleus test. Mutat Res 40: 325–338. Marathias VM, Sawicki MJ, Bolton PH. 1999. 6-Thioguanine alters the structure and stability of duplex DNA and inhibits quadruplex DNA formation. Nucleic Acids Res 27: 2860–2867. Martínez-Rueda JO, Arce-Salinas CA, Kraus A, Alcocer-Varela J, Alarcón-Segovia D. 1996. Factors associated with fetal losses in severe systemic lupus erythematosus. Lupus 5: 113–119. Marushak A, Weber T, Bock J, Birkeland SA, Hansen HE, Klebe J, Kristoffersen K, Rasmussen K, Ølgaard K. 1986. Pregnancy following kidney transplantation. Acta Obstet Gynecol Scand 65: 557–559. Matter BE, Donatsch P, Racine RR, Schmid B, Suter W. 1982. Genotoxicity evaluation of cyclosporin A, a new immunosuppressive agent. Mutat Res 105: 257–264. McConnell JB, Bhoola R. 1973. A neonatal complication of maternal leukemia treated with 6-mercaptopurine. Postgrad Med J 49: 211–213. McGrory CH, Groshek MA, Sollinger HW, Moritz MJ, Armenti VT. 1999. Pregnancy outcomes in female pancreas-kidney recipients. Transplant Proc 31: 652–653. McLeod HL, Krynetski EY, Relling MV, Evans WE. 2000. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 14: 567–572. Meehan RT, Dorsey JK. 1987. Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy. J Rheumatol 14: 252–258. Mercier-Parot L, Tuchmann-Duplessis H. 1967. Obtention de malformations des membres par la 6-mercaptopurine chez trois espèces: lapin, rat et souris. C R Seances Soc Biol Fil 161: 762–768. Merkatz IR, Schwartz GH, David DS, Stenzel KH, Riggio RR, Whitsell JC. 1971. Resumption of female reproductive function following renal transplantation. JAMA 216: 1749–1754. Merrill LK, Board JA, Lee HM. 1973. Complications of pregnancy after renal transplantation including a report of spontaneous uterine rupture. Obstet Gynecol 41: 270–274. Merskey C, Rigal W. 1956. Pregnancy in acute leukemia treated with 6-mercaptopurine. Lancet 2: 1268–1269. Moe PG, Lethinen M, Wegelius R, Friman S, Kreuger A, Berg A. 1979. Progeny of survivors of acute lymphocytic leukemia. Acta Pediatr Scand 68: 301–303. Morini A, Spina V, Aleandri V, Cantonetti G, Lambiasi A, Papalia U. 1998. Pregnancy after heart transplant: update and case report. Hum Reprod 13: 749–757. Morishita S, Imai A, Kawabata I, Tamaya T. 1994. Acute myelogenous leukemia in pregnancy: fetal blood sampling and early effects of chemotherapy. Int J Gynecol Obstet 44: 273–277. Mosesso P, Palitti F. 1993. The genetic toxicology of 6-mercaptopurine. Mutat Res 296: 279–294. Mulvihill JJ, McKeen EA, Rosner F, Zarrabi MH. 1987. Pregnancy outcome in cancer patients. Experience in a large cooperative group. Cancer 60: 1143–1150. Murphy ML. 1960. Teratogenic effects of tumor-inhibiting chemicals in the rat. In: GEW Wolstenholme, CM O'Conner, editors. A CIBA Foundation Symposium on congenital malformations. London: J & A Churchill Ltd. p 78. Myers RL, Schmid R, Newton JJ. 1980. Childbirth after liver transplantation. Transplantation 29: 432. Naqvi R, Sheikh R, Ahmad E, Akhtar F, Hashmi A, Naqvi A, Rizvi A. 1999. Pregnancy in renal allograft recipients. Transplant Proc 31: 3148. Nelson JA, Carpenter JW, Rose LM, Adamson DJ. 1975. Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine. Cancer Res 35: 2872–2878. Neu LT Jr. 1962. Leukemia complicating pregnancy. Two additional case reports. Mo Med 59: 220–221. Nolan GH, Sweet RL, Laros RK, Roure CA. 1974. Renal cadaver transplantation followed by successful pregnancies. Obstet Gynecol 43: 732–739. O'Connell PJ, Caterson RJ, Stewart J